Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 4.724M
March 31, 2026 -114.75M
December 31, 2025 36.77M
September 30, 2025 0.826M
June 30, 2025 -29.70M
March 31, 2025 -138.67M
December 31, 2024 77.09M
September 30, 2024 198.01M
June 30, 2024 199.74M
March 31, 2024 -272.03M
December 31, 2023 99.02M
September 30, 2023 102.49M
June 30, 2023 214.37M
March 31, 2023 58.17M
December 31, 2022 56.36M
September 30, 2022 -374.48M
June 30, 2022 31.87M
March 31, 2022 1.827B
December 31, 2021 -18.42M
September 30, 2021 -17.52M
June 30, 2021 -101.45M
March 31, 2021 2.909M
December 31, 2020 -30.29M
September 30, 2020 -10.19M
June 30, 2020 -8.515M
Date Value
March 31, 2020 -17.27M
December 31, 2019 13.23M
September 30, 2019 619.39M
June 30, 2019 -5.872M
March 31, 2019 -3.61M
December 31, 2018 -398.60M
September 30, 2018 -6.509M
June 30, 2018 -22.04M
March 31, 2018 -25.57M
December 31, 2017 -94.35M
September 30, 2017 -45.20M
June 30, 2017 1.676M
March 31, 2017 -1.385M
December 31, 2016 -9.284M
September 30, 2016 -0.458M
June 30, 2016 -4.325M
March 31, 2016 -0.779M
December 31, 2015 -5.312M
September 30, 2015 -4.965M
June 30, 2015 -3.66M
March 31, 2015 0.56M
December 31, 2014 -9.572M
September 30, 2014 -23.57M
June 30, 2014 29.30M
March 31, 2014 -15.20M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -0.513M
Repligen Corp. -2.089M
Bio-Techne Corp. -7.057M
Codexis, Inc. 0.175M
MetaStat, Inc. --